Pharmaceutical Applications of Dendrimers in Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 159
Special Issue Editor
Interests: nanoparticles; dendrimers; anticancer therapy; theranostic; drug delivery; gene delivery
Special Issue Information
Dear Colleagues,
During the last few decades, dendrimers have become popular in the field of nanomedicine. The unique properties of dendrimers, such as their relatively straightforward synthesis, well-defined shape, and possibility of modifying their structure, mean that they are prospective candidates for cancer treatment. Presently, numerous studies have been conducted regarding the use of dendrimers as theranostic agents. Functionalized dendrimers can also be applied as imaging tools. For this Special Issue, we invite submissions of manuscripts that focus on dendrimer-based nanosystems that could be used in cancer treatment.
Dr. Sylwia Michlewska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dendrimers
- drug delivery
- gene delivery
- anticancer therapy
- nanosystems
- theranostic approach
